Previous Page  2 / 11 Next Page
Information
Show Menu
Previous Page 2 / 11 Next Page
Page Background

Page 19

Volume 2

Journal of Microbiology and Biotechnology Reports

Microbial Biotechnology 2018

September 17-18, 2018

Microbial Biotechnology & Vaccine Design

September 17-18, 2018 Lisbon, Portugal

5

th

World Congress on

The capric acid from

Saccharomyces boulardii

as an antifungal agent: Amechanism study

Anna Krasowska, Jakub Suchodolski and Marcin Lukaszewicz

University of Wroclaw, Poland

Candida albicans

is a pathogenic yeast-like fungus that causes exo- and endogenous infections.

C. albicans

strains exhibit multidrug-

resistance to commonly used antifungal agents which correlate with overexpression of Cdr and Mdr efflux pumps located in the

plasma membrane. Growing resistance of pathogenic

C. albicans

strains to many classes of antifungal drugs has stimulated efforts to

find new agents to combat more invasive infections. A selected number of probiotic organisms,

Saccharomyces boulardii

among them,

have also been tested as potential biotherapeutic agents.

S. boulardii

is a yeast strain that has been shown to have applications in the

prevention and treatment of intestinal infections caused by microbial pathogens. We have similarly shown that

S. boulardii

secretes

capric acid (C10:0), which is most effective in inhibiting essential virulence factors of

C. albicans

, especially morphological transition,

partial adhesion, as well as biofilm formation. Our latest research on the mechanism of action of capric acid and its influence on the

C. albicans

cells clearly show its interaction with the plasma membrane. Capric acid decreases fluidity, while increasing the potential

of the plasma membrane. For these reasons, we have probably not observed antifungal activity of amphotericin B in the presence of

capric acid. The antagonism between capric acid and amphotericin B is a strong indication for physicians to not use both compounds

simultaneously in the treatment of candidiasis.

Biography

Anna Krasowska is an assistant professor at the Department of Biotransformation, University of Wroclaw, Poland. She is currently involved in the isolation and

characterization of biosurfactants produced by arctic microorganisms. She has also examined the activity of lipases and proteases released into the environment

by microorganisms isolated from different environments. Her research interests lie in multidrug resistance of pathogenic microorganisms like

Saccharomyces

cerevisiae,

yeast and

Candida albicans

.

anna.krasowska@uwr.edu.pl

Anna Krasowska et al.,, J Microbio and Biotech Rept 2018, Volume 2